These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

421 related items for PubMed ID: 30803131

  • 1. A novel moisturizer with high sun protection factor improves cutaneous barrier function and the visible appearance of rosacea-prone skin.
    Baldwin H, Santoro F, Lachmann N, Teissedre S.
    J Cosmet Dermatol; 2019 Dec; 18(6):1686-1692. PubMed ID: 30803131
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. A Novel Night Moisturizer Enhances Cutaneous Barrier Function in Dry Skin and Improves Dermatological Outcomes in Rosacea-prone Skin.
    Santoro F, Teissedre S.
    J Clin Aesthet Dermatol; 2018 Dec; 11(12):11-17. PubMed ID: 30666273
    [Abstract] [Full Text] [Related]

  • 5. Use of an alternative method to evaluate erythema severity in a clinical trial: difference in vehicle response with evaluation of baseline and postdose photographs for effect of oxymetazoline cream 1·0% for persistent erythema of rosacea in a phase IV study.
    Eichenfield LF, Del Rosso JQ, Tan JKL, Hebert AA, Webster GF, Harper J, Baldwin HE, Kircik LH, Stein-Gold L, Kaoukhov A, Alvandi N.
    Br J Dermatol; 2019 May; 180(5):1050-1057. PubMed ID: 30500065
    [Abstract] [Full Text] [Related]

  • 6. Skin compatibility and efficacy of a cosmetic skin care regimen with licochalcone A and 4-t-butylcyclohexanol in patients with rosacea subtype I.
    Schoelermann AM, Weber TM, Arrowitz C, Rizer RL, Qian K, Babcock M.
    J Eur Acad Dermatol Venereol; 2016 Feb; 30 Suppl 1():21-7. PubMed ID: 26805419
    [Abstract] [Full Text] [Related]

  • 7. Fabrication and efficacy assessment of combination of brimonidine and ivermectin for treatment of papulopustular rosacea.
    Pakdaman SF, Samadi A, Fattahi M, Naeimifar A, Ardehali FA, Ketabi Y, Nasrollahi SA, Firooz A.
    J Cosmet Dermatol; 2024 Sep; 23(9):2973-2981. PubMed ID: 38831548
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Beneficial use of Cetaphil moisturizing cream as part of a daily skin care regimen for individuals with rosacea.
    Laquieze S, Czernielewski J, Baltas E.
    J Dermatolog Treat; 2007 Sep; 18(3):158-62. PubMed ID: 17538804
    [Abstract] [Full Text] [Related]

  • 14. Efficacy and safety of oxymetazoline cream 1.0% for treatment of persistent facial erythema associated with rosacea: Findings from the 52-week open label REVEAL trial.
    Draelos ZD, Gold MH, Weiss RA, Baumann L, Grekin SK, Robinson DM, Kempers SE, Alvandi N, Weng E, Berk DR, Ahluwalia G.
    J Am Acad Dermatol; 2018 Jun; 78(6):1156-1163. PubMed ID: 29409914
    [Abstract] [Full Text] [Related]

  • 15. A Cosmetic Regimen Formulated to Address the Multi-Modal Pathogenesis of Rosacea Demonstrates Efficacy for Treating Facial Redness and Skin's Appearance.
    Farris PK, Gerstein FH, Baldwin HE, Draelos ZD.
    J Drugs Dermatol; 2024 Sep 01; 23(9):757-763. PubMed ID: 39231085
    [Abstract] [Full Text] [Related]

  • 16. The effect of Cetaphil Gentle Skin Cleanser on the skin barrier of patients with rosacea.
    Draelos ZD.
    Cutis; 2006 Apr 01; 77(4 Suppl):27-33. PubMed ID: 16706247
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. The appearance of facial foundation cosmetics applied after metronidazole gel 1%.
    Draelos ZD, Colón LE, Preston N, Johnson LA, Gottschalk RW.
    Cutis; 2011 May 01; 87(5):251-9. PubMed ID: 21699130
    [Abstract] [Full Text] [Related]

  • 20. Efficacy of a novel rosacea treatment system: an investigator-blind, randomized, parallel-group study.
    Leyden JJ.
    J Drugs Dermatol; 2011 Oct 01; 10(10):1179-85. PubMed ID: 21968669
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.